Cibus, Inc. (NASDAQ:CBUS) Short Interest Update

Cibus, Inc. (NASDAQ:CBUSGet Free Report) was the recipient of a significant increase in short interest in September. As of September 15th, there was short interest totalling 2,410,000 shares, an increase of 11.6% from the August 31st total of 2,160,000 shares. Based on an average daily trading volume, of 222,700 shares, the days-to-cover ratio is presently 10.8 days. Approximately 13.7% of the shares of the stock are short sold.

Hedge Funds Weigh In On Cibus

A number of institutional investors have recently made changes to their positions in the stock. Armistice Capital LLC acquired a new position in shares of Cibus in the second quarter worth $5,083,000. Squarepoint Ops LLC acquired a new position in Cibus in the second quarter valued at $214,000. Old West Investment Management LLC increased its stake in Cibus by 3.6% in the second quarter. Old West Investment Management LLC now owns 53,247 shares of the company’s stock valued at $524,000 after purchasing an additional 1,868 shares during the last quarter. FineMark National Bank & Trust increased its stake in Cibus by 24.3% in the second quarter. FineMark National Bank & Trust now owns 20,488 shares of the company’s stock valued at $202,000 after purchasing an additional 4,000 shares during the last quarter. Finally, Rhumbline Advisers acquired a new position in Cibus in the second quarter valued at $221,000. 33.81% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts recently weighed in on the company. Canaccord Genuity Group upgraded Cibus to a “strong-buy” rating in a research note on Friday, July 19th. Canaccord Genuity Group reduced their price objective on Cibus from $21.00 to $20.00 and set a “buy” rating for the company in a report on Thursday, September 19th. Finally, Alliance Global Partners reduced their price objective on Cibus from $25.00 to $23.50 and set a “buy” rating for the company in a report on Tuesday, September 24th.

Check Out Our Latest Research Report on Cibus

Cibus Stock Performance

Shares of CBUS stock opened at $3.35 on Friday. The stock has a fifty day moving average price of $6.78 and a 200 day moving average price of $12.08. The stock has a market cap of $72.18 million, a PE ratio of -0.18 and a beta of 1.84. Cibus has a 1 year low of $3.33 and a 1 year high of $23.18.

Cibus (NASDAQ:CBUSGet Free Report) last released its quarterly earnings results on Thursday, August 8th. The company reported ($1.14) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.81) by ($0.33). Cibus had a negative return on equity of 29.05% and a negative net margin of 9,856.84%. The company had revenue of $0.84 million during the quarter, compared to analyst estimates of $0.44 million. During the same period last year, the firm earned ($3.05) earnings per share. As a group, equities research analysts predict that Cibus will post -3.84 earnings per share for the current year.

Cibus Company Profile

(Get Free Report)

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.

See Also

Receive News & Ratings for Cibus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cibus and related companies with MarketBeat.com's FREE daily email newsletter.